Adverse Changes in HbA1c, Body Weight and Insulin Use in People With Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
Figures are generally photos, graphs and static images that would be represented in traditional pdf publications.
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.